Product Details
ARANESP 25 MCG/0.42 ML SYRING
Manufacturer: AMGEN
MFG#: 55513-0057-04
NDC: 55513-0057-04
PID: 639354
1/CT
$385.18
In Stock4/CT
$487.62
In StockAdditional Information
| Product Name | Aranesp 25 mcg/0.42 mL Syringe |
| Active Ingredient | Darbepoetin alfa |
| Drug Class | Erythropoiesis-Stimulating Agent (ESA) |
| Mechanism of Action | Stimulates red blood cell production by acting on erythropoietin receptors in the bone marrow |
| Strength | 25 mcg |
| Volume | 0.42 mL |
| Route of Administration | Subcutaneous (SC) injection |
| Side Effects | Headache, fatigue, hypertension, injection site reactions, cardiovascular events (stroke, heart attack, blood clots) |
| Precautions | Monitor for signs of cardiovascular issues, hypertension, and clot formation |
| Storage | Store between 2°C and 8°C (refrigerated), protect from light, do not freeze |
| Packaging | Prefilled syringe containing 25 mcg of darbepoetin alfa in 0.42 mL solution |
| Uses | Treatment of anemia in patients with chronic kidney disease (CKD) and chemotherapy-induced anemia |
Description
Aranesp 25 mcg/0.42 mL Syringe is a biologic medication used to treat anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia in cancer patients. The active ingredient, darbepoetin alfa, is a synthetic form of erythropoietin, a hormone that stimulates red blood cell production in the bone marrow. Aranesp helps increase red blood cell counts, thereby improving oxygen delivery throughout the body and reducing the need for blood transfusions in affected patients.
The medication is administered through a subcutaneous injection, typically given once every one to four weeks, depending on the patient’s condition and response to treatment. Aranesp is especially effective in patients with CKD who are on dialysis or not undergoing dialysis and in those receiving chemotherapy for cancer.
Common side effects include headache, fatigue, hypertension, and injection site reactions. Serious adverse effects may include cardiovascular events such as stroke, heart attack, and blood clots. Patients should be monitored regularly for signs of these complications during treatment.
Frequently Asked Questions (FAQs)
The cost of ARANESP 25 MCG/0.42 ML SYRING is $$385.18
ARANESP 25 MCG/0.42 ML SYRING is manufactured by AMGEN.
You can purchase ARANESP 25 MCG/0.42 ML SYRING on our website at https://supplies.pipelinemedical.com/product/detail/aranesp-25mcg-0-42ml-singleject-pfs-4-bx-639354